Neuropsychological care and rehabilitation of cancer patients with chemobrain

Strategies for evaluation and intervention development

Pascal Jean-Pierre, Douglas E Johnson-Greene, Thomas G. Burish

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Malignant tumors and their various treatments such as chemotherapy, radiotherapy and hormonal therapy can deleteriously affect a large number of cancer patients and survivors on multiple dimensions of psychosocial and neurocognitive functioning. Oncology researchers and clinicians are increasingly cognizant of the negative effects of cancer and its treatments on the brain and its mental processes and cognitive outcomes. Nevertheless, effective interventions to treat cancer and treatment-related neurocognitive dysfunction (CRND), also known as chemobrain, are still lacking. The paucity of data on effective treatments for CRND is due, at least partly, to difficulties understanding its etiology, and a lack of reliable methods for assessing its presence and severity. This paper provides an overview of the incidence, etiology, and magnitude of CRND, and discusses the plausible contributions of psychological, motor function, and linguistic and behavioral complications to CRND. Strategies for reliable neuropsychological screening and assessment, and development and testing of effective ways to mitigate CRND are also discussed.

Original languageEnglish
Pages (from-to)2251-2260
Number of pages10
JournalSupportive Care in Cancer
Volume22
Issue number8
DOIs
StatePublished - Jan 1 2014

Fingerprint

Second Primary Neoplasms
Rehabilitation
Neoplasms
Mental Processes
Therapeutics
Linguistics
Survivors
Radiotherapy
Research Personnel
Psychology
Drug Therapy
Incidence
Brain

Keywords

  • Cancer and cognition
  • Cancer and memory problems
  • Cancer and treatment-related neurocognitive dysfunction
  • Chemobrain
  • Chemotherapy
  • Cognitive disorders
  • Cognitive functioning
  • Malignant tumors
  • Mental performance
  • Neoplasms
  • Neuropsychological tests

ASJC Scopus subject areas

  • Oncology

Cite this

Neuropsychological care and rehabilitation of cancer patients with chemobrain : Strategies for evaluation and intervention development. / Jean-Pierre, Pascal; Johnson-Greene, Douglas E; Burish, Thomas G.

In: Supportive Care in Cancer, Vol. 22, No. 8, 01.01.2014, p. 2251-2260.

Research output: Contribution to journalArticle

@article{47e147040bea4489ac01deb377f69456,
title = "Neuropsychological care and rehabilitation of cancer patients with chemobrain: Strategies for evaluation and intervention development",
abstract = "Malignant tumors and their various treatments such as chemotherapy, radiotherapy and hormonal therapy can deleteriously affect a large number of cancer patients and survivors on multiple dimensions of psychosocial and neurocognitive functioning. Oncology researchers and clinicians are increasingly cognizant of the negative effects of cancer and its treatments on the brain and its mental processes and cognitive outcomes. Nevertheless, effective interventions to treat cancer and treatment-related neurocognitive dysfunction (CRND), also known as chemobrain, are still lacking. The paucity of data on effective treatments for CRND is due, at least partly, to difficulties understanding its etiology, and a lack of reliable methods for assessing its presence and severity. This paper provides an overview of the incidence, etiology, and magnitude of CRND, and discusses the plausible contributions of psychological, motor function, and linguistic and behavioral complications to CRND. Strategies for reliable neuropsychological screening and assessment, and development and testing of effective ways to mitigate CRND are also discussed.",
keywords = "Cancer and cognition, Cancer and memory problems, Cancer and treatment-related neurocognitive dysfunction, Chemobrain, Chemotherapy, Cognitive disorders, Cognitive functioning, Malignant tumors, Mental performance, Neoplasms, Neuropsychological tests",
author = "Pascal Jean-Pierre and Johnson-Greene, {Douglas E} and Burish, {Thomas G.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00520-014-2162-y",
language = "English",
volume = "22",
pages = "2251--2260",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Neuropsychological care and rehabilitation of cancer patients with chemobrain

T2 - Strategies for evaluation and intervention development

AU - Jean-Pierre, Pascal

AU - Johnson-Greene, Douglas E

AU - Burish, Thomas G.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Malignant tumors and their various treatments such as chemotherapy, radiotherapy and hormonal therapy can deleteriously affect a large number of cancer patients and survivors on multiple dimensions of psychosocial and neurocognitive functioning. Oncology researchers and clinicians are increasingly cognizant of the negative effects of cancer and its treatments on the brain and its mental processes and cognitive outcomes. Nevertheless, effective interventions to treat cancer and treatment-related neurocognitive dysfunction (CRND), also known as chemobrain, are still lacking. The paucity of data on effective treatments for CRND is due, at least partly, to difficulties understanding its etiology, and a lack of reliable methods for assessing its presence and severity. This paper provides an overview of the incidence, etiology, and magnitude of CRND, and discusses the plausible contributions of psychological, motor function, and linguistic and behavioral complications to CRND. Strategies for reliable neuropsychological screening and assessment, and development and testing of effective ways to mitigate CRND are also discussed.

AB - Malignant tumors and their various treatments such as chemotherapy, radiotherapy and hormonal therapy can deleteriously affect a large number of cancer patients and survivors on multiple dimensions of psychosocial and neurocognitive functioning. Oncology researchers and clinicians are increasingly cognizant of the negative effects of cancer and its treatments on the brain and its mental processes and cognitive outcomes. Nevertheless, effective interventions to treat cancer and treatment-related neurocognitive dysfunction (CRND), also known as chemobrain, are still lacking. The paucity of data on effective treatments for CRND is due, at least partly, to difficulties understanding its etiology, and a lack of reliable methods for assessing its presence and severity. This paper provides an overview of the incidence, etiology, and magnitude of CRND, and discusses the plausible contributions of psychological, motor function, and linguistic and behavioral complications to CRND. Strategies for reliable neuropsychological screening and assessment, and development and testing of effective ways to mitigate CRND are also discussed.

KW - Cancer and cognition

KW - Cancer and memory problems

KW - Cancer and treatment-related neurocognitive dysfunction

KW - Chemobrain

KW - Chemotherapy

KW - Cognitive disorders

KW - Cognitive functioning

KW - Malignant tumors

KW - Mental performance

KW - Neoplasms

KW - Neuropsychological tests

UR - http://www.scopus.com/inward/record.url?scp=84905095032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905095032&partnerID=8YFLogxK

U2 - 10.1007/s00520-014-2162-y

DO - 10.1007/s00520-014-2162-y

M3 - Article

VL - 22

SP - 2251

EP - 2260

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 8

ER -